Journals / Alpha psychiatry (Online) / 2022 / Cilt: 23 - Sayı: 1

The Effect of Attention Deficit and Hyperactivity Disorder on Treatment Compliance in Individuals Undergoing Probation Addiction Program Treatment

Pages
33–39
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Treatment motivation in patients with ADHD decreases toward the end of the program.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The social and legal problems caused by substance use necessitate compulsory treatment.
📊
Key Findings & Data:The participants were evaluated with a sociodemographic form, the Addiction Profile Index (API), The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES), the Wender Utah Rating Scale, and the Adult Attention Deficit Hyperactivity Disorder Self-Report Scale (ASRS), before commencing the PAP.
💡
Conclusion & Impact:Treatment motivation in patients with ADHD decreases toward the end of the program.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The social and legal problems caused by substance use necessitate compulsory treatment. Individuals with substance use disorder who also have attention deficit and hyperactivity disorder (ADHD) are more frequently prone to crime and more severe substance use. The aim of this study was to investigate the effect of ADHD on the treatment compliance. Methods: One hundred one patients who applied to the Probation Erenköy Mental Health and Neurological Diseases Training and Research Hospital, and who were determined to participate in the probation addiction program (PAP), were included. The participants were evaluated with a sociodemographic form, the Addiction Profile Index (API), The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES), the Wender Utah Rating Scale, and the Adult Attention Deficit Hyperactivity Disorder Self-Report Scale (ASRS), before commencing the PAP. The diagnosis of ADHD was confirmed by interview. After the PAP was completed, participants were re-evaluated Results: It was determined that 67.3% of the participants had ADHD and 41.2% of the patients with ADHD were noncompliant in completing the program. There was no statistically significant relationship between ADHD and treatment compliance. The SOCRATES total values at the beginning of treatment were significantly higher in patients with ADHD. The API total scores were significantly higher in the ADHD group before and after the program. Severe craving and severity of addiction were important factors that increased treatment noncompliance. Conclusion: ADHD is higher in the probation population and the severity of addiction is also higher, both before and after the program. Treatment motivation in patients with ADHD decreases toward the end of the program.

🔖

Cite This Article

AKALIN, B. Y., BİLİCİ, R. (2022). The Effect of Attention Deficit and Hyperactivity Disorder on Treatment Compliance in Individuals Undergoing Probation Addiction Program Treatment. Alpha psychiatry (Online), Cilt: 23 - Sayı: 1, 33–39. https://ajindex.com/articles/434805

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Regnart J, Truter I, Meyer A. Critical exploration of co-occurring attention-deficit/hyperactivity disorder, mood disorder and substance use disorder. Expert Rev Pharmacoecon Outcomes Res. 2017
  2. 17(3):275-282. [CrossRef] 2. Orum MH, Kara MZ, Egilmez OB, Kalenderoglu A. Complete blood count alterations due to the opioid use: what about the lymphocyte-related ratios, especially in monocyte to lymphocyte ratio and platelet to lymphocyte ratio? J Immunoassay Immunochem. 2018
  3. 39(4):365-376. [CrossRef] 3. Altıntoprak A, Akgür S, Coşkunol H. Treatment approaches and toxicological analysis for substance abusers who are being on probation. Türkiye’de Psikiyatri [Psychiatry in Turkey]. 2007
  4. 9(3):166-172. 4. Birliği AP.DSM-5 Tanı Ölçütleri Başvuru El Kitabı, 1. Baskı, Çev. E Köroğlu. Ankara: Hekimler Yayın Birliği
  5. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005
  6. 366(9481):237-248. 6. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007
  7. 164(6):942-948. [CrossRef] 7. McGough JJ, Smalley SL, McCracken JT, et al. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry. 2005
  8. 162(9):1621-1627. [CrossRef] 8. Torgersen T, Gjervan B, Rasmussen K. ADHD in adults: a study of clinical characteristics, impairment and comorbidity. Nord J Psychiatry. 2006
  9. 60(1):38-43. [CrossRef] 9. Moura HF, Faller S, Benzano D, et al. The effects of ADHD in adult substance abusers. J Addict Dis. 2013
  10. 32(3):252-262. [CrossRef] 10. Einarsson E, Sigurdsson JF, Gudjonsson GH, Newton AK, Bragason OO. Screening for attention-deficit hyperactivity disorder and co-morbid mental disorders among prison inmates. Nord J Psychiatry. 2009
  11. 63(5): 361-367. [CrossRef] 11. Doğan S, Öncü B, Varol-Saraçoğlu G, Küçükgöncü S. Validity and reliability of the Turkish version of the Adult ADHD Self-Report Scale (ASRSv1.1). Anadolu Psikiyatr Derg. 2009
  12. 10(2):77-87. 12. Öncü B, Ölmez S, Şentürk V. Validity and reliability of the Turkish version of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. Turk Psikiyatri Derg. 2005
  13. 16(4):252-259. 13. Evren C, Gürol DT, Ögel K. Reliability and validity of the Penn Alcohol Craving Scale (PACS) revised version for substance craving in male substance-dependent inpatients. Turk Psikiyatr Derg. 2011
  14. 22(suppl 1):70. 14. Ögel K, Evren C,